Lack of association of the 3′-UTR polymorphism in the NFKBIA gene with Crohn's disease in an Israeli cohort

International Journal of Colorectal Disease

Volumn 22, Issue 9, 2007, Pages 1021-1025

  Leshinsky Silver, E ^a   Karban, A ^b   Cohen, S ^a   Fridlander, M ^c   Davidowich, O ^d   Kimmel, G ^d   Shamir, R ^d   Levine, A ^d  

^a WOLFSON MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c Danyel Biotech Ltd   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

CARD15; Crohn's; Genotype; NFKBIA; NOD2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 4;

3' UNTRANSLATED REGION; ADOLESCENT; ARTICLE; CHRONIC INFLAMMATION; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HEREDITY; HUMAN; IMMUNE DYSREGULATION; ISRAEL; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL;

3' UNTRANSLATED REGIONS; COHORT STUDIES; CROHN DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; ISRAEL; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC;

EID: 34848899465     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0287-x     Document Type: Article

References (30)

1. Hugot JP, Zouali H, Lesage S, Thomas G (1999) Etiology of the inflammatory bowel diseases. Int J Colorectal Dis 14:2-9
2. Fiocchi C (1998) Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 115:182-205
3. Thompson NP, Driscoll R, Pounder RE, Wakefield AJ (1996) Genetics versus environment in inflammatory bowel disease; results of a British twin study. BMJ 312:95-96
4. Sartor JB (1997) Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92:5S-11S
5. Newman B, Siminovitch K (2003) Inflammatory bowel disease: Crohn's disease and the success of the NODern genetics. Clin Invest Med 26:303-312
6. Mathew C, Lewis CM (2004) Genetics of the inflammatory bowel disease: progress and prospects. Hum Mol Genet 13:161-168
7. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
8. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606
9. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357:1925-1928
10. Inohara N, Nunez G (2001) The NOD: A signaling module that regulates apoptosis and host defense against pathogens. Oncogene 20:6473-6481
11. Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782-787
12. Cario E, Podolsky DK (2000) Differential alternation in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68:7010
13. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviere J, Rutgeerts P (2004) Deficient host-bacteria interactions in inflammatory bowel disease: The toll-like receptor(TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53:987-992
14. Levine A, Karban A, Eliakim R, Shaoul R, Reif S, Pacht A, Wardi J, Yakir B, Leshinsky-Silver E (2005) A polymorphism in the TNF-α promotor gene is associated with pediatric onset and colonic location of Crohn's disease. Am J Gastroenterol 100:407-413
15. Levine A, Raanan A, Wine E, Weiss B, Karban A, Shaoul R, Eliakim R, Reif S, Pacht A, Yakir B, Friedlander M, Kaniel Y, Leshinsky-Silver E (2005) TNF promotor polymorphism and modulation of growth retardation and disease severity in pediatric Crohn's disease. Am J Gastroenterol 100:1-7
16. Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477-484
17. Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, Knuechel R, Baeuerle PA, Scholmerich J, Gross V (1998) Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 15:357-369
18. Neurath MF, Fuss I, Schurmann G, Pettersson S, Arnold K, Muller-Lobeck H, Strober W, Herfarth C, Buschenfelde KH (1998) Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann NY Acad Sci 859:149-159
19. Neurath MF, Pettersson S (1997) Predominant role of NF-kappa B p65 in the pathogenesis of chronic intestinal inflammation. Immunobiology 198:91-98
20. Miterski B, Bohringer S, Klein W, Sindern E, Haupts M, Schimrigk S, Epplen JT (2002) Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations. Genes Immun 3:211-219
21. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE (2000) High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 66:1857-1862
22. Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen JT, Wolff H, Schmiegel WH, Griga T (2004) A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis 19:153-156
23. Glavac D, Ravnik-Glavac M, O'Brien SJ, Dean M (1994) Polymorphisms in the 3′ untranslated region of the I kappa B/MAD-3 (NFKBI) gene located on chromosome 14. Hum Genet 93:694-696
24. Zhang K, Deng M, Chen T, Waterman MS, Sun F (2002) A dynamic programming algorithm for haplotype block partitioning. Proc Natl Acad Sci USA 99:7335-7339
25. Kimmel G, Shamir R (2005) GERBIL: Genotype resolution and block identification using likelihood. Proc Natl Acad Sci USA 102:158-162
26. Wine E, Reif S, Leshinsky-Silver E, Weiss B, Shaoul RR, Shamir R, Wasserman D, Lerner A, Boaz M, Levine A (2004) Pediatric Crohn's disease and growth retardation: The role of genotype, phenotype, and disease severity. Pediatrics 114:1281-1286
27. Leshinsky-Silver E, Karban A, Buzhakor E, Yakir B, Eliakim R, Reif S, Shaul R, Boaz M, Lev D, Levine A (2005) Is age of onset of Crohn's disease governed by mutations in NOD2/CARD15 and Toll-like receptor 4? Evaluation of a pediatric cohort. Pediatr Res 58:499-504
28. Conne B, Stutz A, Vassalli JD (2000) The 3′-untranslated region of messenger RNA: A molecular hotspot for pathology? Nat Med 6:637-641
29. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, Inohara N, Nunez G, Kishi Y, Koike Y, Shimosegawa T, Shimoyama T, Hibi T (2002) Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 123:86-91
30. Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y (2002) Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 47:469-472